African American patients seeking treatment in the public sector: Characteristics of buprenorphine vs. methadone patients

Drug and Alcohol Dependence

Volumn 122, Issue 1-2, 2012, Pages 55-60

  Mitchell, Shannon Gwin ^a   Kelly, Sharon M ^a   Gryczynski, Jan ^a   Myers, C Patrick ^b   Jaffe, Jerome H ^a   O'Grady, Kevin E ^c   Olsen, Yngvild K ^d   Schwartz, Robert P ^a  

^a FRIENDS RESEARCH INSTITUTE   (United States)

^b PM and A Consulting   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d Baltimore Substance Abuse Systems   (United States)

Author keywords

African American patients; Buprenorphine; Methadone; Treatment entry

Indexed keywords

BUPRENORPHINE; DIAMORPHINE; METHADONE;

ADDICTION SEVERITY INDEX; ADULT; AFRICAN AMERICAN; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; FEMALE; FRIENDS SUPPLEMENTAL QUESTIONNAIRE; HELP SEEKING BEHAVIOR; HEROIN DEPENDENCE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE;

ADULT; AFRICAN AMERICANS; BALTIMORE; BUPRENORPHINE; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; METHADONE; MIDDLE AGED; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; PATIENT ADMISSION; PUBLIC SECTOR; SEX FACTORS; SUBSTANCE ABUSE TREATMENT CENTERS; TREATMENT OUTCOME;

EID: 84858437328     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2011.09.009     Document Type: Article

References (17)

1. Auriacombe M., Fatseas M., Dubernet J., Daulouede J.P., Tignol J. French field experience with buprenorphine. Am. J. Addict. 2004, 13(Suppl. 1):S17-S28.
2. Beschner G.M., Walters J.M. Just another habit? Heroin users' perspective on treatment. Life With Heroin: Voices from the Inner City 1985, Lexington Books, Lexington, MA. B. Hanson, G. Beschner, J.M. Walters, E. Bovelle (Eds.).
3. Comer S.D., Sullivan M.A., Hulse G.K. Sustained-release naltrexone: novel treatment for opioid dependence. Expert Opin. Investig. Drugs 2007, 16:1285-1294.
4. Jaffe J.H., O'Keeffe C. From morphine clinics to buprenorphine: regulating opioid agonist treatment of addiction in the United States. Drug Alcohol Depend. 2003, 70(Suppl. 2):S3-S11.
5. Ling W., Casadonte P., Bigelow G., Kampman K.M., Patkar A., Bailey G.L., Rosenthal R.N., Beebe K.L. Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial. JAMA 2010, 304:1576-1583.
6. Mattick R.P., Kimber J., Breen C., Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst. Rev. 2008, (2). Art. No.: CD002207. 10.1002/14651858.CD002207.pub3.
7. McLellan A.T., Luborsky L., Cacciola J., Griffith J., Evans F., Barr H.L., O'Brien C.P. New data from the Addiction Severity Index. Reliability and validity in three centers. J. Nerv. Ment. Dis. 1985, 173:412-423.
8. Mitchell S.G., Kelly S.M., Brown B.S., Reisinger H.S., Peterson J.A., Ruhf A., Agar M.H., Schwartz R.P. Incarceration and opioid withdrawal: the experiences of methadone patients and out-of-treatment heroin users. J. Psychoactive Drugs 2009, 41:145-152.
9. Peterson J.A., Reisinger H.S., Schwartz R.P., Mitchell S.G., Kelly S.M., Brown B.S., Agar M.H. Targeted sampling in drug abuse research: a review and case study. Field Methods 2008, 20:155-170.
10. Peterson J.A., Schwartz R.P., Mitchell S.G., Reisinger H.S., Kelly S.M., O'Grady K.E., Brown B.S., Agar M.H. Why don't out-of-treatment individuals enter methadone treatment programs?. Int. J. Drug Policy 2010, 21:36-42.
11. Rosenblum A., Magura S., Joseph H. Ambivalence toward methadone treatment among intravenous drug users. J. Psychoactive Drugs 1991, 23:21-27.
12. Schwartz R.P., Highfield D.A., Jaffe J.H., Brady J.V., Butler C.B., Rouse C.O., Callaman J.M., O'Grady K.E., Battjes R.J. A randomized controlled trial of interim methadone maintenance. Arch. Gen. Psychiatry 2006, 63:102-109.
13. Schwartz R.P., Kelly S.M., O'Grady K.E., Gandhi D., Jaffe J.H. Interim methadone treatment compared to standard methadone treatment: 4-month findings. J. Subst. Abuse Treat. 2011, 41:21-29.
14. Stancliff S., Myers J.E., Steiner S., Drucker E. Beliefs about methadone in an inner-city methadone clinic. J. Urban Health 2002, 79:571-578.
15. Stanton A. The SAMHSA Evaluation of the Impact of the DATA Waiver Program. Summary Report 2006, WESTAT, Rockville, MD.
16. Umbricht-Schneiter A., Ginn D.H., Pabst K.M., Bigelow G.E. Providing medical care to methadone clinic patients: referral vs on-site care. Am. J. Public Health 1994, 84:207-210.
17. Zweben J.E., Sorensen J.L. Misunderstandings about methadone. J. Psychoactive Drugs 1988, 20:275-281.